<DOC>
	<DOC>NCT00665613</DOC>
	<brief_summary>The purpose of this study is to determine if osteoporosis is an unrecognized complication of chronic anticoagulation with warfarin.</brief_summary>
	<brief_title>The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients on warfarin that have had BMD within a year Patients on bisphosphates, SERMS, anticonvulsants, estrogens, androgens, calcitonin, hctz and thyroid hormone replacement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>warfarin use</keyword>
</DOC>